IDXX - Company ID 0000874716
The table below shows IDEXX LABORATORIES INC /DE's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $266.25M | $237.96M | $198.59M | $183.91M | $114.71M | $124.42M |
| Capital expenditure | $31.98M | $30.03M | $30.27M | $39.51M | $31.84M | $20.16M |
| Investing cash flow | -$33.54M | -$29.61M | -$106.94M | -$39.51M | -$41.84M | -$24.59M |
| Dividends paid | - | - | - | - |
IDEXX LABORATORIES INC /DE reported operating cash flow of $1.18B for fiscal year 2025. That is up 27.2% from $929.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $235.85M (FY 2014) to $1.18B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | $351.04M | $400.89M | $154.76M | $0.00 | $266.30M | $132.26M |
| Financing cash flow | -$211.43M | -$330.32M | -$144.07M | -$146.08M | -$13.48M | -$129.65M |